Selected Publications
Mari Angelica Cayabyab1, Glenda Hoffecker, Lisa Varughese, Victoria Wittner, Jean De Dieu Ndayishimiye, Xingmei Wang, Joseph Bleznuck, Rachel Hatch1, Donna Capozzi, Avni Santani, Hakon Hakonarson, Ryan C. Massa, Nevena Damjanov, Nandi J. Reddy, Randall A. Oyer, Ursina R. Teitelbaum, Sony Tuteja: From paper to practice: Implementing preemptive Dihydropyridine dehydrogenase (DPYD) testing & pharmacogenomic (PGx)-guided dosing to reduce serious treatment-related adverse events (TRAEs) in gastrointestinal malignancies ACCP : 2024.
Monica M. Matsumoto, MD, Enrique F. Schisterman, PhD, Michael C. Soulen, MD, Shilpa Reddy, MD, Mike Sheng, MD, Tamim Khaddash, MD, Nevena Damjanov, MD, Emma E. Furth, MD, Stephen J. Hunt, MD PhD, Gregory J. Nadolski, MD MTR, David E. Kaplan, MD MSc, Terence P.F. Gade, MD PhD: Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma: The Phase I-II qTACE Trial Journal of Vascular and Interventional Radiology : 2024.
Sony Tuteja, Mari Cayabyab, Glenda Hoffecker, Lisa A. Varughese, Jean De Dieu. Ndayishimiye, Victoria Wittner, Xingmei Wang, Margaret Harr, Avni Santani, Hakon Hakonarson, Ryan Massa, Nevena Damjanov, Nandi Reddy, Randy Oyer, Ursina R. Teitelbaum: Implementing DPYD/UGT1A1 testing to prevent treatment related adverse events (TRAE) in patients with gastrointestinal (GI) cancer: results of a pragmatic implementation trial J Clin Oncol : 2024.
Michael C Soulen, Ursina R Teitelbaum, Rosemarie Mick, Jennifer Eads, Jeffrey I Mondschein, Mandeep Dagli, Diana van Houten, Nevena Damjanov, Charles Schneider, Keith Cengel, David C Metz: Integrated capecitabine-temozolomide with radioembolization for liver-dominant G2 NETs: long-term outcomes of a single-institution retrospective study Cardiovasc Intervent Radiol
: 2024.
Sony Tuteja, Mari Cayabyab, Glenda Hoffecker, Lisa A. Varughese, Jean D. Ndayishimiye, Victoria Wittner, Xingmei Wang, Rachel Hatch, Donna Capozzi, Margaret Harr, Avni Santani, Hakon Hakonarson, Ryan Massa, Nevena Damjanov, Nandi Reddy, Randy Oyer, Ursina R. Teitelbaum: Implementing DPYD/UGT1A1 testing to prevent treatment related adverse events (TRAEs) in patients with gastrointestinal (GI) cancer: results of a pragmatic implementation trial ClinPGx 2024: Knowledge, Implementation & Education : 2024.
Jeffrey W. Shevach, MD, Lisa B. Aiello, PhD, RN, AOCNS, Julie A. Lynch, PhD, RN, MBA, Jeffrey Petersen, MD, Lori Hoffman-Hogg, MS, RN, CNS, AOCN, Deborah Hartzfeld, MS, Margaret Lundquist, DNP, MPH, CRNP, Michael J. Kelley, MD, Maren T. Scheuner, MD, MPH, Robert Montgomery, MD Nevena Damjanov, MD Kyle Robinson, MD, Yu-Ning Wong, MD, Darshana Jhala, MD, Ravi B. Parikh, MD, MPH, and Kara N. Maxwell, MD, PhD: On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans JCO Oncology Practice 19 (8): 2023.
Damjanov, N: Clinical Edge Journal Scan Commentary: HCC MDEdge : 2022.
Damjanov, N: Clinical Edge Journal Scan Commentary: HCC MDEdge : 2022.
Damjanov, N: Clinical Edge Journal Scan Commentary: HCC MDEdge : 2022.
Damjanov, N: Clinical Edge Journal Scan Commentary: HCC MDEdge : 2022.
Academic Contact Information
Penn Presbyterian Medical Center
51 North 39th Street
220 MOB
Philadelphia,
PA
19104
Phone: 215-662-8488
Patient appointments: 800-789-7366